Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Medical Device Prototype Development

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, titled Medical Device Prototype Development, involves the design and manufacture of reconstructive transplant device prototypes for prime contractors supporting Defense Health Agency research projects. The scope of work includes engineering design and fabrication for translational research, with a specific requirement that all designs support future FDA regulatory filings or international equivalents. The final deliverables consist of physical device prototypes and comprehensive technical design documentation. The opportunity is associated with the Department of Defense under the Defense Health Agency Contracting Activity and falls under NAICS code 339113. It was posted on August 26, 2026, with a response deadline of November 4, 2026.

General Info

Subcontract for designing and manufacturing reconstructive transplant device prototypes for Defense Health Agency.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

339113 - Surgical Appliance and Supplies ManufacturingView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of HT942526RTRPIIRA.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Reconstructive Transplant, Investigator-Initiated Research Award

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Designs and manufactures prototypes for reconstructive transplant devices for prime contractors on Defense Health Agency research projects. Performs engineering design and fabrication for translational research. Ensures design supports future FDA regulatory filings or international equivalents. Delivers physical device prototypes and technical design documentation.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
Grant
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Solicitation # HT942526BCRPBTA122
The Defense Health Agency Contracting Activity is soliciting applications for the fiscal year 2026 Breast Cancer Research Program Breakthrough Award Levels 1 and 2 under solicitation HT942526BCRPBTA122. This program supports high-potential research aimed at achieving breakthroughs in breast cancer, with an expected total allotment of approximately 10.6 million dollars to fund roughly six applications. Funding Level 1 focuses on innovative, high-risk research in early stages of development to achieve proof of concept, while Funding Level 2 supports research validated by substantial preliminary or published data. The program also includes a Population Science Studies option within Level 2. Applications may be submitted by a single Principal Investigator or through a partnering PI option involving an Initiating PI and a Partnering PI. The maximum period of performance is three years for standard awards and four years for Population Science Studies. Funding limits vary by level and PI structure, ranging from 750,000 dollars for Level 1 single PI awards up to 3.35 million dollars for Level 2 Population Science partnering PI awards. Evaluation is based on scored criteria including impact, research strategy, feasibility, and personnel qualifications, with additional programmatic reviews for portfolio composition and innovation. Applicants must be registered in the System for Award Management and submit a two-step application process, with pre-applications due by November 4, 2026, and full applications due by November 18, 2026. Required documentation includes a project narrative, statement of work, and various abstracts, with strict adherence to PDF naming conventions and page limits.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

in 2 months
View Details
NAICS: 541715
Grant
DoW Breast Cancer, Clinical Research Extension Award
Solicitation # HT942526BCRPCREA2
The Defense Health Agency Contracting Activity is soliciting applications for the fiscal year 2026 Breast Cancer Research Program Clinical Research Extension Award under solicitation HT942526BCRPCREA2. This grant opportunity supports research aimed at extending data collection, follow-up, and analysis of breast cancer clinical studies to mitigate knowledge loss resulting from early trial termination, limited patient follow-up, or suboptimal sample and data collection. The program emphasizes increasing the clinical relevance of patient participation and may include deeper molecular analysis of clinical samples. All applications must address at least one of the FY26 BCRP overarching challenges or provide a strong justification for an exception. The application process is a two-step submission requiring a pre-application Letter of Intent by November 4, 2026, and a full application by November 18, 2026. Submissions are handled via the Electronic Biomedical Research Application Portal for pre-applications and intramural organizations, while extramural organizations must use Grants.gov. The award allows for a single Principal Investigator or a partnering PI option involving an Initiating PI and a Partnering PI. A critical requirement is the inclusion of at least two breast cancer consumer advocates on the research team. The maximum period of performance is four years. Evaluation follows a two-tier system consisting of a peer review for technical merit and a programmatic review for relevance. Scored criteria include the project's impact on overarching challenges, research strategy and feasibility, the research sharing plan, and, for partnering PI options, the strength of the partnership. Required documentation for the full application includes a project narrative, statement of work, impact statement, and various abstracts. Organizations must maintain active registration in the System for Award Management and provide a unique entity identifier.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

in 2 months
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS